Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
health insurance
Manufacturing
Experts hold line against mass compounding of GLP-1 obesity meds
The recent implosion of Novo’s team-up with telehealth firm Hims & Hers suggests there is still very much a demand for imitation weight loss drugs.
Fraiser Kansteiner
Jun 27, 2025 10:36am
Folx Health scores new client for its LGBTQIA-focused healthcare
Mar 17, 2023 7:40am
Gilead's newer Descovy spurned by UHC in PrEP: report
Aug 14, 2020 11:23am
Expanded BMS, Eli Lilly programs aim to help laid-off workers
Apr 7, 2020 10:30am
Insurers push back on Novartis’ $2.1M SMA gene therapy: report
Jul 3, 2019 8:16am
Novartis explores 'reinsurance model' for next-gen drugs: FT
Dec 17, 2018 11:34am
